An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Quantum-Si to Participate at Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Quantum-Si Incorporated (NASDAQ: QSI) announced participation in two investor conferences featuring President and COO Patrick Schneider. The Canaccord Genuity 42nd Annual Growth Conference is on August 10, 2022, at 8:30 am ET, and the UBS Genomics 2.0 and MedTech Innovations Summit is on August 11, 2022, at 3:00 pm PT. Discussions will focus on the company's advancements in commercializing its innovative Platinum™ instrument for single-molecule protein sequencing. Archived webcasts will be available on Quantum-Si's website.
Positive
None.
Negative
None.
GUILFORD, Conn.--(BUSINESS WIRE)--
Jul. 29, 2022 --Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next generation single molecule protein sequencing platform, today announced that it will be participating in two upcoming investor conferences. Patrick Schneider, Quantum-Si’s President and Chief Operating Officer, will participate in fireside chats at both events. The discussions will cover recent company developments, including progress toward commercialization of Quantum-Si’s groundbreaking PlatinumTM instrument, which will be the first system to enable next-generation, single-molecule protein sequencing.
Canaccord Genuity 42nd Annual Growth Conference
Patrick Schneider, President and Chief Operating Officer, will participate in a fireside chat on Wednesday, August 10, 2022 at 8:30 am ET.
UBS Genomics 2.0 and MedTech Innovations Summit
Patrick Schneider, President and Chief Operating Officer, will participate in a fireside chat on Thursday, August 11, 2022 at 3:00 pm PT.
Live and archived webcasts of the events will be available in the Investors section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
What are the dates for Quantum-Si's upcoming investor conferences?
Quantum-Si will participate in the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, and the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2022.
Who will represent Quantum-Si at the investor conferences?
Patrick Schneider, President and Chief Operating Officer, will represent Quantum-Si at both conferences.
What key topic will be discussed at Quantum-Si's investor conferences?
The discussions will focus on the company's progress toward the commercialization of the Platinum™ instrument for single-molecule protein sequencing.
Where can I access the webcasts for Quantum-Si's investor conferences?
Live and archived webcasts will be available in the Investors section of Quantum-Si's website.
What is Quantum-Si's focus in the life sciences sector?
Quantum-Si is focused on revolutionizing proteomics with their next-generation single-molecule protein sequencing technology.
